Daisuke Mikami

793 total citations
30 papers, 593 citations indexed

About

Daisuke Mikami is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Daisuke Mikami has authored 30 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Nephrology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Daisuke Mikami's work include Renal Diseases and Glomerulopathies (8 papers), Hormonal Regulation and Hypertension (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Daisuke Mikami is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Hormonal Regulation and Hypertension (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Daisuke Mikami collaborates with scholars based in Japan, Bangladesh and Germany. Daisuke Mikami's co-authors include Kazuko Kamiyama, Masayuki Iwano, Takanobu Taniguchi, Hideki Kimura, Mamiko Kobayashi, Naoki Takahashi, Kenji Kasuno, Seiji Yokoi, Takashi Yazawa and Junsuke Uwada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Daisuke Mikami

30 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daisuke Mikami Japan	14	334	153	94	71	63	30	593
Lihua Li China	17	306 0.9×	95 0.6×	99 1.1×	79 1.1×	104 1.7×	42	717
Hilda Vargas‐Robles Mexico	17	281 0.8×	124 0.8×	114 1.2×	105 1.5×	117 1.9×	42	821
Stefan Wallner Germany	13	474 1.4×	206 1.3×	75 0.8×	84 1.2×	105 1.7×	32	842
Mayumi Matsumoto Japan	12	253 0.8×	91 0.6×	60 0.6×	106 1.5×	53 0.8×	38	941
Yoshitake Cho United States	16	462 1.4×	209 1.4×	86 0.9×	96 1.4×	56 0.9×	27	781
Kathryn M. Spitler United States	15	285 0.9×	126 0.8×	98 1.0×	69 1.0×	125 2.0×	18	749
Shinichiro Koike United States	10	211 0.6×	307 2.0×	148 1.6×	55 0.8×	97 1.5×	20	676
Heng Miao China	14	371 1.1×	126 0.8×	108 1.1×	63 0.9×	203 3.2×	37	809
Emi Arikawa Canada	13	282 0.8×	215 1.4×	207 2.2×	41 0.6×	99 1.6×	16	692
Oliver Murch United Kingdom	12	236 0.7×	106 0.7×	61 0.6×	86 1.2×	134 2.1×	21	674

Countries citing papers authored by Daisuke Mikami

Since Specialization

Citations

This map shows the geographic impact of Daisuke Mikami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Mikami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Mikami more than expected).

Fields of papers citing papers by Daisuke Mikami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Mikami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Mikami. The network helps show where Daisuke Mikami may publish in the future.

Co-authorship network of co-authors of Daisuke Mikami

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Mikami. A scholar is included among the top collaborators of Daisuke Mikami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Mikami. Daisuke Mikami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kimura, Hideki, Kazuko Kamiyama, Mamiko Kobayashi, et al.. (2022). Fenofibrate reduces cisplatin-induced apoptosis by inhibiting the p53/Puma/Caspase-9 pathway and the MAPK/Caspase-8 pathway rather than by promoting autophagy in murine renal proximal tubular cells. Biochemistry and Biophysics Reports. 30. 101237–101237. 8 indexed citations

Nishikawa, Sho, Naoki Takahashi, Seiji Yokoi, et al.. (2022). Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine. CEN Case Reports. 12(1). 32–38. 1 indexed citations

Yazawa, Takashi, Takahiro Sato, Takahiro Nemoto, et al.. (2021). 11-Ketotestosterone is a major androgen produced in porcine adrenal glands and testes. The Journal of Steroid Biochemistry and Molecular Biology. 210. 105847–105847. 13 indexed citations

Kimura, Hideki, Seiji Yokoi, Kazuko Kamiyama, et al.. (2021). PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells. Clinical and Experimental Nephrology. 25(6). 598–607. 7 indexed citations

Uwada, Junsuke, et al.. (2020). PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptor, directly inhibits p38 MAPK. Biochemical Pharmacology. 182. 114297–114297. 13 indexed citations

Kasuno, Kenji, Seiji Yokoi, Sho Nishikawa, et al.. (2020). Preemptive HLA Antibody Screening Prior to Episodic Transplant Renal Biopsy Enables Early Diagnosis and Therapeutic Response in Asymptomatic Chronically Active Antibody-Related Rejection: A Case Report. Transplantation Proceedings. 52(9). 2750–2753. 1 indexed citations

Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2020). Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(6). 158666–158666. 29 indexed citations

Yokoi, Seiji, Kenji Kasuno, Sho Nishikawa, et al.. (2020). Analytical and clinical validation of rapid chemiluminescence enzyme immunoassay for urinary thioredoxin, an oxidative stress-dependent early biomarker of acute kidney injury. Clinica Chimica Acta. 507. 271–279. 7 indexed citations

Yazawa, Takashi, Yoshitaka Imamichi, Junsuke Uwada, et al.. (2019). Evaluation of 17β-hydroxysteroid dehydrogenase activity using androgen receptor-mediated transactivation. The Journal of Steroid Biochemistry and Molecular Biology. 196. 105493–105493. 19 indexed citations

10.

Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2019). β-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells. Life Sciences. 222. 125–132. 24 indexed citations

11.

Uwada, Junsuke, Takashi Yazawa, Daisuke Mikami, et al.. (2019). Store-operated calcium entry (SOCE) contributes to phosphorylation of p38 MAPK and suppression of TNF-α signalling in the intestinal epithelial cells. Cellular Signalling. 63. 109358–109358. 13 indexed citations

12.

Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2019). β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells. Journal of Pharmacological Sciences. 142(1). 1–8. 30 indexed citations

13.

Morikawa, Yukie, Naoki Takahashi, Kazuko Kamiyama, et al.. (2018). Elevated Levels of Urinary Extracellular Vesicle Fibroblast-Specific Protein 1 in Patients with Active Crescentic Glomerulonephritis. The Nephron journals/Nephron journals. 141(3). 177–187. 14 indexed citations

14.

Kobayashi, Mamiko, Daisuke Mikami, Hideki Kimura, et al.. (2017). Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells. Biochemical and Biophysical Research Communications. 486(2). 499–505. 159 indexed citations

15.

Kimura, Hideki, Daisuke Mikami, Kazuko Kamiyama, et al.. (2014). Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells. Biochemical and Biophysical Research Communications. 454(2). 320–327. 13 indexed citations

16.

Mikami, Daisuke, Hideki Kimura, Kazuko Kamiyama, et al.. (2013). Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells. Hypertension Research. 37(5). 422–431. 28 indexed citations

17.

Kimura, Hideki, Ryoichi Miyazaki, Daisuke Mikami, et al.. (2011). Smaller low‐density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: Associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low‐density lipoprotein size. Nephrology. 16(6). 558–566. 5 indexed citations

18.

Kimura, Hideki, Xuan Li, Kunio Torii, et al.. (2010). Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells. Clinical and Experimental Nephrology. 15(1). 34–40. 11 indexed citations

19.

Kimura, Hideki, Xuan Li, Kunio Torii, et al.. (2009). Dexamethasone enhances basal and TNF-α-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11β-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells. Nephrology Dialysis Transplantation. 24(6). 1759–1765. 13 indexed citations

20.

Piao, Hailan, Takanobu Taniguchi, Seigo Nakamura, et al.. (2000). Cloning of rabbit α1b-adrenoceptor and pharmacological comparison of α1a-, α1b- and α1d-adrenoceptors in rabbit. European Journal of Pharmacology. 396(1). 9–17. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact